Literature DB >> 8166269

Pulsatility does not alter the response to a physiological increment in glucagon in the conscious dog.

R L Dobbins1, S N Davis, D W Neal, C Cobelli, A D Cherrington.   

Abstract

The present study was designed to investigate if pulsatile hyperglucagonemia of physiological magnitude has greater efficacy in stimulating hepatic glucose production than constant glucagon. Paired studies were performed in conscious dogs. After insulin and glucagon were clamped at basal concentrations for 2 h, glucagon was elevated for 4 h with either a continuous infusion or pulses having physiological frequency and amplitude. With continuous infusion, plasma glucagon concentrations increased from 56 +/- 7 to 194 +/- 27 ng/l. With pulsatile infusion, glucagon concentrations started at 53 +/- 6 ng/l and then oscillated between 157 +/- 15 and 253 +/- 28 ng/l. Plasma insulin concentrations remained constant at basal levels. Glucose production was determined using a time-varying two-compartment model for glucose kinetics and deconvolution. After 15 min, glucose production had risen from 13.6 +/- 1.1 to 53.8 +/- 3.9 mumol.kg-1.min-1 with continuous infusion and from 12.9 +/- 0.6 to 50.6 +/- 2.9 mumol.kg-1.min-1 with pulsatile infusion. After 4 h, the production had fallen to 16.1 +/- 1.2 and 17.1 +/- 0.7 mumol.kg-1.min-1. In the present animal model with insulin held constant, no difference was noted between the response to continuous or pulsatile glucagon infusion.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8166269     DOI: 10.1152/ajpendo.1994.266.3.E467

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  11 in total

1.  Comparison of the direct and indirect effects of epinephrine on hepatic glucose production.

Authors:  C A Chu; D K Sindelar; D W Neal; E J Allen; E P Donahue; A D Cherrington
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

Review 2.  Pulsatile insulin secretion, impaired glucose tolerance and type 2 diabetes.

Authors:  Leslie S Satin; Peter C Butler; Joon Ha; Arthur S Sherman
Journal:  Mol Aspects Med       Date:  2015-01-28

3.  Peripherally delivered hepatopreferential insulin analog insulin-406 mimics the hypoglycaemia-sparing effect of portal vein human insulin infusion in dogs.

Authors:  Justin M Gregory; Guillaume Kraft; Melanie F Scott; Doss W Neal; Ben Farmer; Marta S Smith; Jon R Hastings; Peter Madsen; Thomas B Kjeldsen; Susanne Hostrup; Christian L Brand; Christian Fledelius; Erica Nishimura; Alan D Cherrington
Journal:  Diabetes Obes Metab       Date:  2019-07-08       Impact factor: 6.577

Review 4.  Physiologic action of glucagon on liver glucose metabolism.

Authors:  C J Ramnanan; D S Edgerton; G Kraft; A D Cherrington
Journal:  Diabetes Obes Metab       Date:  2011-10       Impact factor: 6.577

5.  Insulin's direct effects on the liver dominate the control of hepatic glucose production.

Authors:  Dale S Edgerton; Margaret Lautz; Melanie Scott; Carrie A Everett; Kathryn M Stettler; Doss W Neal; Chang A Chu; Alan D Cherrington
Journal:  J Clin Invest       Date:  2006-02       Impact factor: 14.808

6.  Insulin-induced hypoglycemia increases hepatic sensitivity to glucagon in dogs.

Authors:  Noelia Rivera; Christopher J Ramnanan; Zhibo An; Tiffany Farmer; Marta Smith; Ben Farmer; Jose M Irimia; Wanda Snead; Margaret Lautz; Peter J Roach; Alan D Cherrington
Journal:  J Clin Invest       Date:  2010-11-15       Impact factor: 14.808

7.  Effect of 11 beta-hydroxysteroid dehydrogenase-1 inhibition on hepatic glucose metabolism in the conscious dog.

Authors:  Dale S Edgerton; Rita Basu; Christopher J Ramnanan; Tiffany D Farmer; Doss Neal; Melanie Scott; Peer Jacobson; Robert A Rizza; Alan D Cherrington
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-02-16       Impact factor: 4.310

8.  Glucose autoregulation is the dominant component of the hormone-independent counterregulatory response to hypoglycemia in the conscious dog.

Authors:  Justin M Gregory; Noelia Rivera; Guillaume Kraft; Jason J Winnick; Ben Farmer; Eric J Allen; E Patrick Donahue; Marta S Smith; Dale S Edgerton; Phillip E Williams; Alan D Cherrington
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-05-16       Impact factor: 4.310

9.  Effects of intraportal exenatide on hepatic glucose metabolism in the conscious dog.

Authors:  Dale S Edgerton; Zhibo An; Kathryn M S Johnson; Tiffany Farmer; Ben Farmer; Doss Neal; Alan D Cherrington
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-05-14       Impact factor: 4.310

10.  The kinetics of glucagon action on the liver during insulin-induced hypoglycemia.

Authors:  Christina Pedersen; Guillaume Kraft; Dale S Edgerton; Melanie Scott; Ben Farmer; Marta Smith; David C Laneve; Phillip E Williams; L Merkle Moore; Alan D Cherrington
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-03-24       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.